XYMOGEN® Investor Relations Contact

Kim M. Johnson
Executive Assistant to Brian Blackburn, CEO
XYMOGEN®

(800) 647-6100
Kim.Johnson@XYMOGEN.com

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

XYMOGEN®
Exclusive Professional Formulas
725 S. Kirkman Rd, Orlando, FL 32811
800-647-6100

XYMOGEN® Investor Relations Contact

XYMOGEN® Investor Contact Information